Related Experiment Video

Updated: Jun 22, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

A20 is overexpressed in glioma cells and may serve as a potential therapeutic target

Qingdong Guo1, Hui Dong, Xiaonan Liu

  • 1The Fourth Military Medical University, Xijing Hospital, Department of Neurosurgery, Xi'an 710032, China.

Expert Opinion on Therapeutic Targets
|June 5, 2009
PubMed
Abstract

Insights

Tumor suppressor gene A20 is overexpressed in human glioma, driving tumor growth. Inhibiting A20 significantly slowed glioma cell proliferation in vitro and in mouse models, suggesting A20 as a potential therapeutic target for glioma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Expression

Background:

  • A20 is a TNF-inducible gene with known anti-apoptotic functions in cancer.
  • Its role in human glioma tumorigenesis requires further investigation.

Purpose of the Study:

  • To investigate A20 expression in human glioma tissues and cell lines.
  • To determine the effect of A20 on glioma cell tumorigenesis and evaluate its therapeutic potential.

Main Methods:

  • Reverse transcription-PCR (RT-PCR), western blotting, and immunohistochemistry were used to assess A20 expression.
  • Flow cytometry analyzed cell cycle progression.
  • A xenograft mouse model was employed to evaluate A20 knockdown using siRNAs.

Main Results:

  • A20 was overexpressed in 63.9% of clinical glioma samples, correlating with advanced stages.
  • All tested glioma cell lines expressed A20, with U87 showing the highest levels.
  • A20 inhibition via siRNA reduced glioma cell growth, induced G1/S arrest, increased apoptosis, and suppressed tumor growth in mice.

Conclusions:

  • A20 is significantly overexpressed in human glioma, contributing to tumor development.
  • Inhibiting A20 effectively hinders glioma cell growth in vitro and in vivo.
  • A20 represents a promising therapeutic target for human glioma treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...